AbbVie and Iambic Partner on AI-Driven Drug Discovery
AbbVie and Iambic partner to accelerate Artificial Intelligence (AI)-driven small molecule drug discovery across immunology, neuroscience and oncology.
AbbVie Iambic Partnership | 22/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy